NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $396,000 | +292.1% | 10,000 | -77.8% | 0.02% | +260.0% |
Q3 2022 | $101,000 | -88.8% | 45,000 | +118.4% | 0.01% | -84.4% |
Q2 2022 | $903,000 | -0.1% | 20,600 | +64.8% | 0.03% | +23.1% |
Q1 2022 | $904,000 | -31.4% | 12,501 | -23.1% | 0.03% | +30.0% |
Q4 2021 | $1,318,000 | +29.2% | 16,257 | +85.5% | 0.02% | -20.0% |
Q3 2021 | $1,020,000 | -26.1% | 8,762 | -11.5% | 0.02% | -28.6% |
Q3 2020 | $1,380,000 | +256.6% | 9,904 | +205.6% | 0.04% | +400.0% |
Q2 2020 | $387,000 | +20.9% | 3,241 | +1.2% | 0.01% | -61.1% |
Q1 2020 | $320,000 | +3.2% | 3,201 | -41.0% | 0.02% | +200.0% |
Q3 2018 | $310,000 | +40.3% | 5,429 | +112.7% | 0.01% | +100.0% |
Q1 2018 | $221,000 | -76.3% | 2,553 | -74.3% | 0.00% | -72.7% |
Q1 2017 | $931,000 | – | 9,937 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |